Skip to main content

Advertisement

Table 1 Patients’ characteristics

From: Serum microRNA-1233 is a specific biomarker for diagnosing acute pulmonary embolism

n 30
Age (mean ± SD) 62 ± 14
Male 17/30 (57 %)
CTA confirmed central PE (pulmonary trunk, main pulmonary arteries) 100 %
Risk stratefication (PE-related early mortality rate)
 High (>15 %) 4/30 (13 %)
 Intermediate (3–15 %) 15/30 (50 %)
 Low (<1 %) 11/30 (37 %)
Symptoms
 Dyspnoea 24/30 (81 %)
 Chest pain 10/30 (33 %)
 Cough 3/30 (10 %)
 Syncope 3/30 (10 %)
 Haemoptysis 2/30 (7 %)
 Collaps with subsequent CPR 4/30 (13 %)
Idiopathic DVT/PE 13/30 (43 %)
Secondary DVT/PE
 Malignancy 4/30 (13 %)
 Post surgery 4/30 (13 %)
 Immobilisation 2/30 (7 %)
 Thrombophilia 1/30 (3 %)
 Previous DVT/PE 2/30 (7 %)
 Oral contraceptive therapy 2/30 (7 %)
 Obesity (BMI ≥ 30 kg/m2) 12/30 (40 %)
US confirmed DVT 25/30 (83 %)
  1. Characteristics of acute pulmonary embolism (PE) patients at the time of the emergency room presentation (1st day)
  2. CTA computed tomography (pulmonary) angiography, CPR cardiopulmonary resuscitation, DVT deep vein thrombosis, BMI body mass index, US ultrasound, SD standard deviation